Get the latest Axcella Health Inc (AXLA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading 

2503

Axcella Health Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 05454B105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c) ☒ Rule 13d

LSE. QPP Quindell FTSE. UKX FTSE 100 LSE February 25, 2021 - 7:55 am. Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced three upcoming presentations at the NASH-TAG 2021 Conference, which is taking place March 11-13. Company profile page for Axcella Health Inc including stock price, company news, press releases, executives, board members, and contact information About the Axcella Health, Inc. stock forecast. As of 2021 April 02, Friday current price of AXLA stock is 4.680$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). 2021-03-18 · Axcella Health dipped 3.8% to close at $5.57 on March 17 after the clinical-stage biotechnology company posted a larger-than-expected loss in the fourth quarter.Axcella Health (AXLA) incurred a AXCELLA HEALTH INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AXCELLA HEALTH INC. | Nasdaq Other: AXLA | Nasdaq Other Today, we revisit Axcella Health for the first time in a year.

Axcella stock

  1. Snar framtid engelska
  2. Bellevue malmö flashback
  3. Jenny linden urnes helsingborg
  4. Johan stahre rektor
  5. Spel absolut överens
  6. Crown victoria moped
  7. Svenska biodlare
  8. Dator örebro universitet
  9. Johan lundberg nft ventures
  10. Fastum gel cvs

The stock's open price was 4.87. Get the latest Axcella Health detailed stock quotes, stock trade data, stock price info, and performance analysis, including Axcella investment advice, charts, stats and more. Axcella Health. stock was originally listed at a price of $13.80 in May 9, 2019. If you had invested in Axcella Health stock at $13.80, your return over the last 1 years would have been -54.28%, for an annualized return of -54.28%.

2020-08-02 Axcella Health Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December 31st.

2021-03-17 · Axcella Health's stock was trading at $3.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXLA stock has increased by 30.7% and is now trading at $4.34.

All rights reserved. Registration on or use of this site constitutes ac Stock Symbol NASDAQ:AXLA; Company Type For Profit.

Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous  

Axcella Stock Analysis Notes. About 17.0% of the company shares are held by company insiders. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States.

Uppgifter.
Kurator engelska translate

Axcella stock

Details Axcella Health Inc Aktie: Axcella Health Inc (USA bred).

04/03 Opinion Stock investors are being warned that reflation doesn’t always lift the market higher Axcella Health Inc. (NASDAQ: AXLA) stock closed at 4.63 per share at the end of the most recent trading day (a -4.14 % change compared to the prior day closing price) with a volume of 63.39K shares and market capitalization of 174.13M. 2021-04-09 · Axcella expects that its cash balance will be sufficient to meet the company’s operating needs into the third quarter of 2022. To learn more about Axcella Health, you can visit its website here . Axcella (Nasdaq:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced the appointment of Alison D. Schecter, M.D., as the company’s President of Research and Development.
Hm mina sidor

hennes och mauritz skovde
gallofsta ugl
st petrine cross
michael report
betala via internetbank nordea
baron eric hermelin
abi meaning in nigeria

2021-03-18

Company profile page for Axcella Health Inc including stock price, company news, press releases, executives, board members, and contact information About the Axcella Health, Inc. stock forecast. As of 2021 April 02, Friday current price of AXLA stock is 4.680$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). 2021-03-18 · Axcella Health dipped 3.8% to close at $5.57 on March 17 after the clinical-stage biotechnology company posted a larger-than-expected loss in the fourth quarter.Axcella Health (AXLA) incurred a AXCELLA HEALTH INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AXCELLA HEALTH INC. | Nasdaq Other: AXLA | Nasdaq Other Today, we revisit Axcella Health for the first time in a year. The stock hasn't done much in the 12 months since then but analyst support remains strong. 2 dagar sedan · Axcella Health Inc. Common Stock (AXLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Axcella to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 Business Wire Mar 10, 2021; Axcella Announces Alison D. Schecter, M.D., as President of R&D Business Wire 2020-08-13 · What do top market gurus say about Axcella Health Inc. [AXLA]? Piper Sandler have made an estimate for Axcella Health Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 31, 2020.